Market Tracker

11/24 2:58pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.82
Real-Time Quote
 +0.05 / +0.74%
Today’s Change
3.10
Today|||52-Week Range
7.45
+27.95%
Year-to-Date

Today’s Trading

Previous close6.77
Today’s open6.89
Day’s range6.77 - 7.10
Volume924,949
Average volume (3 months)977,846
Market cap$470.9M
Dividend yield--
Data as of 2:41pm ET, 11/24/2014

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+115.79%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratio135.8
Price/Sales37.83
Price/Book5.21

Competitors

 Today’s
change
Today’s
% change
ZFGNZafgen Inc+0.54+2.61%
AMPHAmphastar Pharmaceut...-0.03-0.28%
SPPISpectrum Pharmaceuti...+0.13+1.72%
PETXAratana Therapeutics...+0.60+4.64%
Data as of 2:55pm ET, 11/24/2014

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts